Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Cash from Financing Activities (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Cash from Financing Activities for 17 consecutive years, with $23.9 million as the latest value for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 87.19% year-over-year to $23.9 million; the TTM value through Mar 2026 reached $318.5 million, up 11.13%, while the annual FY2025 figure was $481.3 million, 17.45% down from the prior year.
  • Cash from Financing Activities hit $23.9 million in Q1 2026 for Acadia Healthcare Company, down from $193.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $483.1 million in Q1 2024 and bottomed at -$75.1 million in Q2 2022.
  • Average Cash from Financing Activities over 5 years is $53.8 million, with a median of $2.0 million recorded in 2022.
  • Year-over-year, Cash from Financing Activities tumbled 1133.2% in 2023 and then skyrocketed 4368.68% in 2024.
  • Acadia Healthcare Company's Cash from Financing Activities stood at -$17.3 million in 2022, then soared by 67.31% to -$5.7 million in 2023, then soared by 1528.88% to $80.8 million in 2024, then soared by 139.24% to $193.3 million in 2025, then tumbled by 87.63% to $23.9 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $23.9 million, $193.3 million, and $43.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.